Browsing by Author Kefford, Richard F

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2016Association of pembrolizumab with tumor response and survival among patients with advanced melanomaHersey, Peter; Daud, Adil; et al, Various; Hamid, Omid; Hodi, F. Stephen; Hwu, Wen-Jen; Joshua, Anthony M.; Kefford, Richard F; Patnaik, Amita; Ribas, Antoni; Wolchok, Jedd D.; Northern Clinical School: SurgeryAssociation of pembrolizumab with tumor response and survival among patients with advanced melanoma, JAMA: The Journal of the American Medical Association, vol.315, 15, 2016,pp 1600-1609
2016Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohortByth Wilson, Karen; Carlino, Matteo; Carlos, Giuliana R M; Fernandez Penas, Pablo; Hwang, Shelley; Wakade, Deepal; Chou, Shaun; Kefford, Richard F; Kong, Benjamin; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort, Journal Of The American Academy Of Dermatology, vol.74, 3, 2016,pp 455-461
2015Targeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanomaCarlino, Matteo; Long, Georgina; Kefford, Richard F; Rizos, Helen; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreTargeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanoma, Critical Reviews in Oncology / Hematology (online), vol.96, 3, 2015,pp 385-398